Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Enovis

Health Tech & Medtech · Wilmington, United States · Founded 1995 · IPO 2008 Unicorn

Medical technology firm dedicated to creating clinically distinct solutions

Valuation
$2.69B
Market cap · May/2026
Revenue
$2.25B
Latest reported FY
EBITDA
$430M
Latest reported FY

Global footprint

Where Enovis has talent and traffic

AI talent share
0.2% of workforce is AI talent
(6 of 3,691 staff)
Core AI30.08%
Other AI30.08%
Non-AI workforce3,68599.84%
Workforce by country
34 countries with
team presence
🇺🇸 United States58.2%
🇮🇹 Italy8.9%
🇲🇽 Mexico8.5%
🇨🇭 Switzerland3.3%
🇬🇧 United Kingdom3.3%
Top 5 of 34 shown
Web traffic by country
90K monthly visits
across markets
🇺🇸 United States42.8%
🇬🇧 United Kingdom8.8%
🇨🇦 Canada6.2%
🇦🇺 Australia5.8%
🇩🇪 Germany5.4%
Top 5 markets shown

Patent intelligence

$112M patent portfolio · 107 active families

Estimated portfolio value
$112M
4.2% of market cap · comparable to top peer Corindus ($93M)
107 active patent families
Where Enovis innovates Biomedical engineeringSacroiliac jointMechanical engineeringProsthesisProsthetic graft

Where Enovis concentrates vs peers

Each axis is a top-10 topic across Enovis and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Enovis's 7 investments and acquisitions.

Every disclosed deal where Enovis appeared as a backer or acquirer, 2007–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Enovis's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Enovis deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Enovis's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        What the market is saying about Enovis

        An AI-synthesized read of the highest-engagement posts about Enovis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Enovis on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.